BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4589321)

  • 1. A comparison of clinical and histopathologic features of childhood malignant lymphoma in Uganda.
    Magrath IT; Ziegler JL; Templeton AC
    Cancer; 1974 Jan; 33(1):285-94. PubMed ID: 4589321
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features and treatment of childhood malignant lymphoma in Uganda.
    Ziegler JL; Morrow RH; Templeton AC; Templeton C; Bluming AZ; Fass L; Kyalwazi SK
    Int J Cancer; 1970 May; 5(3):415-25. PubMed ID: 4916223
    [No Abstract]   [Full Text] [Related]  

  • 3. Childhood non-Hodgkin's lymphoma--a study of 17 cases in Israel.
    Aghai E; Hulu N; Virag I; Kende G; Ramot B
    Cancer; 1974 May; 33(5):1411-6. PubMed ID: 4362957
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant lymphomas in children. A clinico-pathologic retrospective study. II. Non-Hodgkin's lymphomas.
    Garwicz S; Landberg T; Akerman M
    Acta Paediatr Scand; 1974 Sep; 63(5):679-86. PubMed ID: 4606779
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of patients with non-Hodgkin's lymphoma.
    Carbone PP
    Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-Hodgkin's lymphomas and malignant histiocytosis in children.
    Dehner LP
    Semin Oncol; 1977 Sep; 4(3):273-86. PubMed ID: 335517
    [No Abstract]   [Full Text] [Related]  

  • 7. Burkitt's tumor and childhood lymphosarcoma.
    Wright DH
    Clin Pediatr (Phila); 1967 Feb; 6(2):116-23. PubMed ID: 5630405
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.
    Sherins RJ; DeVita VT
    Ann Intern Med; 1973 Aug; 79(2):216-20. PubMed ID: 4580112
    [No Abstract]   [Full Text] [Related]  

  • 9. The "large cell" malignant lymphomas. A retrospective morphological analysis.
    Leahu S
    Med Interne; 1980; 18(3):333-8. PubMed ID: 6997976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of Burkitt's lymphoma of the face and jaws.
    Ziegler JL; Wright DH; Kyalwazi SK
    Cancer; 1971 Mar; 27(3):503-14. PubMed ID: 4994331
    [No Abstract]   [Full Text] [Related]  

  • 11. Soft Tissue B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma Diagnosed by Fine Needle Aspiration Cytology.
    Beljan Perak R; Pavlovic A; Lozic B; Sundov D; Piljic Burazer M; Soljic V
    Acta Cytol; 2015; 59(4):355-7. PubMed ID: 26315277
    [No Abstract]   [Full Text] [Related]  

  • 12. High dose imtermittent intravenous cyclophosphamide in non-Hodgkin's lymphomas: long-term patient follow-up.
    O'Connell MJ; Wiernik PH; Sutherland JC
    Oncology; 1976; 33(4):170-2. PubMed ID: 798149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior mediastinal compression: a report of five cases by malignant lymphoma.
    Olumide AA; Osunkoya BO; Ngu VA
    Cancer; 1971 Jan; 27(1):193-202. PubMed ID: 5107431
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive chemotherapy for a patient with primary cutaneous diffuse large B-cell lymphoma with Burkitt-like morphology.
    Okudaira T; Nagasaki A; Miyagi T; Taira T; Ohshima K; Takasu N
    Intern Med; 2009; 48(6):475-8. PubMed ID: 19293550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma: recent observations on natural history and intensive treatment.
    Carbone PP
    Cancer; 1972 Dec; 30(6):1511-6. PubMed ID: 4565816
    [No Abstract]   [Full Text] [Related]  

  • 16. Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
    Gormley RP; Madan R; Dulau AE; Xu D; Tamas EF; Bhattacharyya PK; LeValley A; Xue X; Kumar P; Sparano J; Ramesh KH; Pulijaal V; Cannizzaro L; Walsh D; Ioachim HL; Ratech H
    Am J Clin Pathol; 2005 Nov; 124(5):790-8. PubMed ID: 16203284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma.
    Rieken J; Bernard V; Witte HM; Peter W; Merz H; Olschewski V; Hertel L; Lehnert H; Biersack H; von Bubnoff N; Feller AC; Gebauer N
    Br J Haematol; 2021 Apr; 193(1):138-149. PubMed ID: 32945554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the lymphomas.
    DeVita VT; Canellos GP
    Semin Hematol; 1972 Apr; 9(2):193-209. PubMed ID: 4111886
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.